Background: HELLP syndome is a life-threatening condition complicating 0,5-0,9% of all pregnancies. It is characterized by endothelial dysfunction associated with microangiopathy. The syndrome is named after the triad of diagnostic criteria: Hemolysis, Elevated Liver enzyme levels, and Low Platelet levels, and it is mostly classified using The Mississippi-Triple Class System. The basic treatment usually involves early delivery, antihypertensive drugs, high-dose magnesium sulphate, corticosteroids and close monitoring of fluid balance and coagulation parameters. About 30% of the cases develop